Karl J. Safulko

[Karl J. Safulko @KJSafulko]

I just completed a really fun Mentimeter Quiz https://t.co/m34fIJiMRG #mentimeterquiz via @mentimeter

[Volodymyr Zelenskyy / Володимир Зеленський @ZelenskyyUa]

Without additional weaponry, this war will become an endless bloodbath, spreading misery, suffering, and destruction. Mariupol, Bucha, Kramatorsk – the list will be continued. Nobody will stop Russia except Ukraine with Heavy Weapons. #ArmUkraineNow

[Karl J. Safulko @KJSafulko]

@DukeMBB @accnetwork Let's Go Duke!!!

[Karl J. Safulko @KJSafulko]

WHOIS@WEONCOLOGISTS

[Karl J. Safulko @KJSafulko]

Pembrolizumab Ph3 wows in 1st line NSCLC regardless of PDL-1 status #patientdeathriskreduction #Keytrudachemocombo https://t.co/1IllkKHyKi https://t.co/Y33Ud13ZsN

[Karl J. Safulko @KJSafulko]

Clearly a need to revisit the sensitivity, accuracy and reliability of the diagnostics with regard to #DNArepairdefects. Confidence in therapeutic decision making based on diagnostic results a requisite; eliminating the risk of fa…https://t.co/Zhti2Ck9ag https://t.co/fyGCS7A7Eg

[Karl J. Safulko @KJSafulko]

Delivery of primary care medicine only evolving to keep pace with society's expectations; immediate gratification! This business model was born NOT in a boardroom of a mega corporation but as an entrepreneur's vision of how to mee…https://t.co/pQnQrR8Y1S https://t.co/uvZSfGm1ZB

[Karl J. Safulko @KJSafulko]

Hope global collaboration will jump start groundbreaking discoveries to benefit patients suffering from this cancer! https://t.co/MSlreMnDX5 https://t.co/OonuWqDljz

[Karl J. Safulko @KJSafulko]

Verastem is able to bring duvelisib to the goal line after Infinity fumbled its way through multiple collaborations. Congratulations! If FDA approved, only time will tell if it fairs better than the small group of PI3K inhibitors…https://t.co/fyQqWf3u9o https://t.co/yAxt9jJQsl

[Karl J. Safulko @KJSafulko]

Defining #valueinoncologytreatment - a daunting task & slippery slope; many factors to be weighed & POVs considered! https://t.co/wNmilH3Cls https://t.co/sWcfTsOYYN

[Karl J. Safulko @KJSafulko]

Possible new treatments for HCC?! FDA also to review Exelixis' #cabozantinib regulatory submission on #CELESTIALdata https://t.co/x1Rb7WdjaI https://t.co/Epwyx1p0fy

[Karl J. Safulko @KJSafulko]

Encouraging news for low risk patients with stage III colon cancer on platinum based adjuvant therapy; reduced risk of neuropathy #IDEA https://t.co/rYE3yFDN9w https://t.co/YHHURySdsV

[Karl J. Safulko @KJSafulko]

Kudos to Dr. Holland for the courage & determination to use chemotherapy, alone and in combination despite the skepticism of his peers. Groundbreaking clinical work that laid the foundation for today's successes in combination therapy! https://t.co/1enWcbLhSF

[NIH History Office @historyatnih]

James F. Holland, physician who helped show chemotherapy could treat cancer, dies at 92, read his oral history at https://t.co/iqlxrUw0TE. https://t.co/OMLSI6DWre @theNCI @NIH

[Karl J. Safulko @KJSafulko]

Immuno-oncology therapy providing our own innate defenses with the leverage to adapt and overcome! #CARTcell #Immunotherapy https://t.co/gl9FI4UVOy

[National Cancer Institute @theNCI]

Treating cancer with CAR T-cells is like giving patients a “living drug.” https://t.co/jJFsDiRiHr #immunotherapy #CARTcell #ImmunoOnc

[Karl J. Safulko @KJSafulko]

NYC's biotech scene gets cash and office space with Beacon's new incubator - https://t.co/xYRuIooSuh

[Karl J. Safulko @KJSafulko]

Bright future for Indocyanine Green dye #ICG first developed by Kodak back in 1955 and now being tested to help identify elusive tumor cells during oncologic surgery. https://t.co/O5eyDEUgfp https://t.co/whKPLBZi9d

[Karl J. Safulko @KJSafulko]

Cancer treatment breakthroughs driving #cancersurvivorship creating a growing & greying cohort requiring our support https://t.co/QXnDr7Yntp

[Karl J. Safulko @KJSafulko]

Fantastic opportunity to mobilize your social network & raise funds for patient advocacy!! #WorldCancerDay #JimKelly https://t.co/UDqtBZqS5B

[Karl J. Safulko @KJSafulko]

Demonstrating true progress toward early cancer detection through 'state-of-the-art' #liquidbiopsy #cancerSEEK. https://t.co/nSh6mHTkqd

[Karl J. Safulko @KJSafulko]

Sanofi returns to hemophilia after RPR spun off Armour Pharmaceutical & its factor replacement products 20 years ago https://t.co/KFqMCJmdt9